IBB icon

iShares Biotechnology ETF
IBB

Overview Fund Activity

891 hedge funds and large institutions have $5.32B invested in iShares Biotechnology ETF in 2024 Q1 according to their latest regulatory filings, with 101 funds opening new positions, 245 increasing their positions, 308 reducing their positions, and 66 closing their positions.

Holders
891
Holders Change
+26
Holders Change %
+3.01%
% of All Funds
12.92%
Holding in Top 10
11
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+10%
% of All Funds
0.16%
New
101
Increased
245
Reduced
308
Closed
66
Calls
$222M
Puts
$1.07B
Net Calls
-$848M
Net Calls Change
+$220M

Top Buyers

1
Goldman Sachs
1
Goldman Sachs
New York
$441M
2
Thrivent Financial for Lutherans
2
Thrivent Financial for Lutherans
Minnesota
$92.9M
3
BNP Paribas Financial Markets
3
BNP Paribas Financial Markets
France
$282M
4
Citigroup
4
Citigroup
New York
$355M
5
Two Sigma Investments
5
Two Sigma Investments
New York
$42.2M

Top Sellers

1
Morgan Stanley
1
Morgan Stanley
New York
$371M
2
Bank of America
2
Bank of America
North Carolina
$1.05B
3
JPMorgan Chase & Co
3
JPMorgan Chase & Co
New York
$221M
4
IUHSA
4
Itau Unibanco Holding S.A.
Brazil
$0
5
MPM
5
MBB Public Markets
Illinois
$4.01M
Name Holding Trade Value Shares
Change 		Shares
Change %
AWM
951
Able Wealth Management
New Jersey
– -$5.67K -42 Closed
BWM
952
BKM Wealth Management
Wisconsin
– -$5.43K -40 Closed
VF
953
VitalStone Financial
Texas
– -$4K -30 Closed
LWANC
954
Laurel Wealth Advisors (North Carolina)
North Carolina
– -$2.72K -20 Closed
DWM
955
Dogwood Wealth Management
Kansas
– -$1.91K -14 Closed
RIM
956
Rockbridge Investment Management
New York
– -$1.9K -14 Closed
SA
957
Scarborough Advisors
Maryland
– -$543 -4 Closed
C
958
Covestor
United Kingdom
– -$1K -4 Closed
35 36 37 38
39